抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產(chǎn)品編號(hào) | 圖片 | 產(chǎn)品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
Balsalazide，≥99% | C17H15N3O6 | |||
|
|
|||||
|
Motolimod (VTX-2337)，99% | C28H34N4O2 | |||
|
|
|||||
|
Suplatast Tosilate，98% | C23H33NO7S2 | |||
|
|
|||||
|
IRAK inhibitor 3，98% | C21H21N5O4S | |||
|
|
|||||
|
ESONARIMOD，98% | C14H16O4S | |||
|
|
|||||
|
HPGDS inhibitor 1，99% | C19H19F4N3O | |||
|
|
|||||
|
24-homo-1,25-dihydroxyvitamin D3，95% | C28H46O3 | |||
|
|
|||||
|
IRAK抑制劑1，≥98% | C17H19N5 | |||
|
|
|||||
|
IRAK inhibitor 6，98% | C20H20N4O3S | |||
|
|
|||||
|
Lusutrombopag，98% | C29H32Cl2N2O5S | |||
|
|
|||||
|
SB 290157 三氟乙酸鹽，≥97%(HPLC) | C24H29F3N4O6 | |||
|
|
|||||
|
FK 3311，98% | C15H13F2NO4S | |||
|
|
|||||
|
TYRPHOSTIN AG 126，98% | C10H5N3O3 | |||
|
|
|||||
|
GSK2190915 (sodium salt)，99% | C38H42N3NaO4S | |||
|
|
|||||
|
APY0201，98% | C23H23N7O | |||
|
|
|||||
|
Iguratimod，99% | C17H14N2O6S | |||
|
|
|||||
|
Pirodavir，98% | C21H27N3O3 | |||
|
|
|||||
